Annalaura Mastrangelo
Annalaura Mastrangelo is an Italian pharmacologist who co-authored a significant study on atherosclerosis. Her collaboration includes developing a drug that effectively blocks the receptor for propionato de imidazol, potentially preventing the progression of atherosclerosis in patients. This groundbreaking work showcases her commitment to advancing cardiovascular health research.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| Spain | 1 | 8.00 | 0.08% | +0% | 46,754,778 | 35,340 | $1,400,000 | 1,058$ |
| Totals | 1 | 46,754,778 | 35,340 | $1,400,000 | 1,058$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Spain:
Annalaura Mastrangelo is a co-author of the experimental treatment patented alongside David Sancho.
8